Iright
BRAND / VENDOR: Biolegend

Biolegend, 515403, FITC anti-human/mouse Granzyme B Antibody, 25tests

CATALOG NUMBER: 515403
Precio habitual$0.99
/
Los gastos de envío se calculan en la pantalla de pagos.
  • In stock, ready to ship

  • Pedido pendiente, envío pronto

Este sitio está protegido por hCaptcha y se aplican la Política de privacidad de hCaptcha y los Términos del servicio.

Product Description

Granzyme B is a 32 kD serine protease, also known as granzyme-2, serine protease B, CCP1, Asp-ase, and CTLA-1. Granzyme B is abundantly stored in the granules of cytotoxic T lymphocytes and NK cells. Low level of expression has been reported in granulocytes, B cells, and activated dendritic cells. Granzyme B is crucial for rapid induction of cell death and apoptosis through interaction with mannose-6-phosphate receptor.
25tests
Verified Reactivity: Human, Mouse
Reported Reactivity: Rat
Antibody Type: Monoclonal
Host Species: Mouse
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation: The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration: Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: ICFC - Quality tested
Recommended Usage: Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.
Excitation Laser: Blue Laser (488 nm)
Application References(PubMed link indicates BioLegend citation): Wever PC, et al. 1998. Immunology. 93:383 Arens R, et al. 2004. J. Exp. Med. 199:1595 Lima M, et al. 2003. Am. J. Pathol. 163:763 Wiede F, et al. 2014. J Autoimmun. 53:105. PubMed Baker GF, et al. 2014. Cancer Res. 74:5079. PubMed Nacer A, et al. 2014. PLoS Pathog. 10:1004528. PubMed Sharma SK, et al. 2015. J Immunol. 194:5529. PubMed
Product Citations: Chan LC, et al. 2019. J Clin Invest. 129:3324. PubMed Deng G, et al. 2022. J Immunother Cancer. 10:. PubMed Ou W, et al. 2023. Nat Commun. 14:392. PubMed Cheng MI, et al. 2023. Nat Immunol. 24:780. PubMed Xiao C, et al. 2023. Nat Aging. 3:418. PubMed Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed Xin B, et al. 2022. Hepatology. 76:630. PubMed Vorkas CK, et al. 2022. J Immunol. 208:1042. PubMed McMurray JL, et al. 2022. Cell Rep. 39:110858. PubMed Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed An HW, et al. 2022. Cell Rep. 41:111878. PubMed Lin YH 2023. Immunity. 56(1):207-223.e8. PubMed Sieow JL, et al. 2023. Int J Mol Sci. 24: . PubMed Kuehm LM, et al. 2021. Cancer Immunol Res. 9:227. PubMed Drijvers JM, et al. 2021. Cancer Immunol Res. 9:184. PubMed Khojandi N, et al. 2021. Cancer Immunol Res. 9:214. PubMed Wu MJ, et al. 2022. Cancer Discov. 12:812. PubMed AbuEid M, et al. 2021. iScience. 24(6):102653. PubMed Donnarumma T, et al. 2016. Cell Rep. 17:1571-1583. PubMed Baker G, et al. 2014. Cancer Res. 74:5079. PubMed Denk D, et al. 2022. Immunity. 55:2059. PubMed Wang W, et al. 2022. World J Gastrointest Oncol. 14:1124. PubMed van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed Leeansyah E, et al. 2015. PLoS Pathog. 11: 1005072. PubMed Shen T, et al. 2019. Cell Death Discov. 5:123. PubMed Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed Ron–Harel N, et al. 2019. Cell Rep. 28:3011. PubMed Chow MT et al. 2019. Immunity. 50(6):1498-1512 . PubMed Xiao C, et al. 2022. iScience. 25:103934. PubMed Figueroa-Romero C, et al. 2022. Front Immunol. 13:773288. PubMed Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed Di Blasi D, et al. 2019. Cell Mol Gastroenterol Hepatol. 0.510416667. PubMed LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed Rafiq S, et al. 2018. Nat Biotechnol. 36:847. PubMed Kramer KJ, et al. 2022. Nat Commun. 13:3466. PubMed Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed Sharma S, et al. 2015. J Immunol. 194:5529. PubMed Wu W, et al. 2020. Oncol Lett. 0.91875. PubMed Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed Islas-Vazquez L, et al. 2020. Biology (Basel). 9:00. PubMed Kreutmair S, et al. 2021. Immunity. . PubMed Hu J, et al. 2020. Biomed Pharmacother. 127:110229. PubMed Lucas C, et al. 2021. Nature. Online ahead of print. PubMed Adams NM et al. 2018. Immunity. 48(6):1172-1182 . PubMed Wu L, et al. 2022. Theranostics. 12:842. PubMed Fujigaki J, et al. 2015. PLoS One. 10: 0132521. PubMed Bastiaens G, et al. 2016. Am J Trop Med Hyg. 94: 663 - 673. PubMed Wiedemann GM, et al. 2020. Cell Rep. 33:108498. PubMed Diaz–Salazar C, et al. 2020. Cell Rep. 32:108186. PubMed Huang CH, et al. 2020. Adv Ther (Weinh). 3:. PubMed Ulrich-Lewis JT, et al. 2022. Front Immunol. 13:861710. PubMed Xu S, et al. 2021. Immunity. . PubMed Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed Walk J, et al. 2020. Front Immunol. 2.405555556. PubMed van Montfoort N, et al. 2018. Cell. 175:1744. PubMed Sheng W et al. 2018. Cell. 174(3):549-563 . PubMed Vardam-Kaur T, et al. 2021. Oncotarget. 12:2051. PubMed Bradley T et al. 2018. Cell. 175(2):387-399 . PubMed LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed Luo Y, et al. 2021. Nat Commun. 12:3913. PubMed Webb ER, et al. 2022. iScience. 25:104995. PubMed Koikawa K, et al. 2021. Cell. 184:4753. PubMed Prado-Garcia H, et al. 2017. Cancer Immunol Immunother. 10.1007/s00262-017-1979-x. PubMed Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed Leclerc M, et al. 2019. Nat Commun. 10:3345. PubMed Su S et al. 2018. Cell. 175(2):442-457 . PubMed Jeng MY, et al. 2018. J Exp Med. 215:51. PubMed Peluso MJ, et al. 2021. Cell Rep. 36:109518. PubMed Wiede F, et al. 2014. J Autoimmun. 53:105. PubMed Kumagai S, et al. 2020. Immunity. 53(1):187-203.e8. PubMed Kmieciak M, et al. 2011. J Immunol. 187:708. PubMed Zhang J, et al. 2018. Nature. 553:91. PubMed Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed Maleki KT, et al. 2021. Cell Reports Medicine. 2(3):100220. PubMed Zhang H, et al. 2021. Cell Reports. 35(6):109096. PubMed Sagebiel AF, et al. 2019. Nat Commun. 10:975. PubMed Lettau M, et al. 2018. Int Immunol. 30:215. PubMed Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed Thieme CJ, et al. 2020. Cell Rep Med. 1:100092. PubMed Dhar P, et al. 2021. Commun Biol. 4:905. PubMed Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed Kansy BA, et al. 2017. Cancer Res. 77:6353. PubMed Sheppard S, et al. 2021. Cell Reports. 35(9):109210. PubMed Hu X, et al. 2020. Neoplasia. 1.290972222. PubMed Deng J, et al. 2021. J Leukoc Biol. 110:1171. PubMed Loo Yau H, et al. 2021. STAR Protocols. 2(2):100549. PubMed Loo Yau H, et al. 2021. Molecular Cell. 81(7):1469-1483.e8. PubMed Dubrot J, et al. 2021. Immunity. 54(3):571-585.e6. PubMed Ajith A, et al. 2019. FASEB J. 33:5220. PubMed Geary CD et al. 2018. Cell reports. 24(8):1949-1957 . PubMed Lin J, et al. 2021. Cancer Immunol Res. 9:1413. PubMed DiMarco AV, et al. 2022. Cancer Immunol Res. 10:70. PubMed McAusland TM, et al. 2021. Mol Ther Oncolytics. 20:306. PubMed Li Q, et al. 2022. J Biol Chem. :101753. PubMed Malenica I, et al. 2021. Nat Commun. 12:5209. PubMed Vonderhaar EP, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:41. PubMed Ruth JH, et al. 2021. JCI Insight. 6:e145662. PubMed Durand J, et al. 2015. J Immunol. 195: 5035 - 5044. PubMed Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed Gorby C, et al. 2020. Sci Signal. :13. PubMed Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed Sethuraman SN, et al. 2020. Theranostics. 10:3397. PubMed Carrion B, et al. 2021. Neurol Neuroimmunol Neuroinflamm. 8:. PubMed Liu Y, et al. 2021. Nat Commun. 12:6831. PubMed Li X, et al. 2021. Front Cell Dev Biol. 9:647713. PubMed
RRID: AB_2114575 (BioLegend Cat. No. 515403)
Structure: 32 kD serine protease
Distribution: Cytotoxic T-cells and NK cells, low on granulocytes, B cells and activated dendritic cells
Function: Induction of cell death and apoptosis
Ligand/Receptor: Mannose-6-phosphate receptor
Cell Type: B cells, Dendritic cells, NK cells, T cells
Biology Area: Cell Biology, Immunology, Innate Immunity, Neuroscience
Molecular Family: Enzymes and Regulators, Proteases
Antigen References: 1. Estebanez-Perpina E, et al. 2000. Biol Chem. 381:1203 2. Griffiths GM. And S. Isaaz, et al. 1993. J. Cell Biol. 120:885 3. Spaeny-Dekking EH, et al. 1998. J. Immunol. 160:3610 4. Wagner C, et al. 2008. Mol. Immunol. 45:1761
Gene ID: 300214939171528
UniProt: View information about Granzyme B on UniProt.org
Clone: GB11
Regulatory Status: RUO
Other Names: Granzyme-2, serine protease B, CCP1, Asp-ase, CTLA-1
Isotype: Mouse IgG1, κ


Order Guidelines

1. Price & Stock Available on Request. 📧Click to send email to: service@iright.com

2. Please DO NOT make payment before confirmation.

3. Minimum order value of $1,000 USD required.

Collaboration

Tony Tang

📧Email: Tony.Tang@iright.com

📱Mobile/WhatsApp/Wechat: +86-17717886924